Browse by Authors and Editors
Number of items: 5. 2018Simpson, Rosalind C., Murphy, Ruth, Bratton, Daniel J., Sydes, Matthew R., Wilkes, Sally, Nankervis, Helen, Dowey, Shelley, Bell, Hazel, Cruickshank, Margaret E., Gibbon, Karen, Green, Cathy M., Wong, Christina, Owen, Caroline M., London, Kate, Haque, Shaheen and Thomas, Kim S. (2018) Help for future research- lessons learned in trial design, recruitment and delivery from the 'hELP' study. Journal of Lower Genital Tract Disease . ISSN 1526-0976 (In Press) 2016Thomas, Kim S., Batchelor, Jonathan M., Bath-Hextall, Fiona, Chalmers, Joanne, Clarke, Tessa, Crowe, Sally, Delamere, Finola M., Eleftheriadou, Viktoria, Evans, Nicholas, Firkins, Lester, Greenlaw, Nicola, Lansbury, Louise E., Lawton, Sandra, Layfield, Carron, Leonardi-Bee, Jo, Mason, James, Mitchell, Eleanor, Nankervis, Helen, Norrie, John, Nunn, Andrew, Ormerod, Anthony D., Patel, Ramesh, Perkins, William, Ravenscroft, Jane C., Schmitt, Jochen, Simpson, Eric, Whitton, Maxine E. and Williams, Hywel C. (2016) A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease. Programme Grants for Applied Research, 4 (18). pp. 1-488. ISSN 2050-4330 Nankervis, Helen, Thomas, K.S., Delamere, Finola M., Barbarot, S., Smith, S., Rogers, Natasha K. and Williams, Hywel C. (2016) What is the evidence-base for atopic eczema treatments? A summary of published randomised controlled trials. British Journal of Dermatology, 176 (4). pp. 910-927. ISSN 1365-2133 Wilkes, Sally R., Nankervis, Helen, Tavernier, Elsa, Maruani, Annabel and Williams, Hywel C. (2016) How clinically relevant are treatment comparisons of topical calcineurin inhibitor trials for atopic eczema? Journal of Investigative Dermatology, 136 (10). pp. 1944-1949. ISSN 1523-1747 Nankervis, Helen, Thomas, K.S., Delamere, Finola M., Barbarot, Sebastien, Rogers, Natasha K. and Williams, Hywel C. (2016) Scoping systematic review of treatments for eczema. Programme Grants for Applied Research, 4 (7). pp. 1-480. ISSN 2050-4322 |